Considerations governing factor IX product choice in hemophilia B

Transfusion. 1994 Jun;34(6):554-5. doi: 10.1046/j.1537-2995.1994.34694295077.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Contamination / prevention & control
  • Factor IX / therapeutic use*
  • Hemophilia B / drug therapy*
  • Humans
  • Virus Diseases / prevention & control
  • Virus Diseases / transmission

Substances

  • Factor IX